Therapy Areas: Central Nervous System
3 March 2021 - - US-based life science company Aegea Biotechnologies, Inc and molecular diagnostic assays, products and services provider Biocept, Inc. (NASDAQ: BIOC) have inked a supply agr...
1 March 2021 - - The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the approval of Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy in pat...
26 February 2021 - - The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the approval of Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy in...
25 February 2021 - - Results from the EMERGENT-1 Phase 2 clinical trial evaluating KarXT for the treatment of schizophrenia were published in the New England Journal of Medicine, UK-based clinica...
16 February 2021 - - The US Food and Drug Administration has cleared French phase 3 gene therapy platform company Lysogene's (FR0013233475 LYS) (PAR: LYS) Investigational New Drug application for...
12 February 2021 - - US-based Kite, a Gilead Company (NASDAQ: GILD), has released findings from a new analysis of the ZUMA-1 trial of Yescarta (axicabtagene ciloleucel) in adult patients with rel...